ACADIA PHARMACEUTICALS INC (ACAD) Stock Cash Flow
NASDAQ:ACAD - Nasdaq - US0042251084 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 228.90M | 226.45M | -61.29M | -215.98M | -167.87M | |||
| Depreciation Amortization | 10.59M | 15.88M | 5.55M | 2.03M | 3.35M | |||
| Change In Working Capital | -870.00K | 4.16M | 18.00M | 37.99M | -24.82M | |||
| Taxes Paid | N/A | 20.00M | 5.85M | 2.19M | 1.04M | |||
| Other non cash items | -92.74M | -89.00M | 54.00M | 61.92M | 63.69M | |||
| OPERATING CASH FLOW | 149.00M | 158.00M | 17.00M | -114.04M | -125.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -520.00K | -40.00M | 0.00 | -1.12M | |||
| Other Investing Activity | -41.00M | -30.00M | 72.00M | 73.24M | -69.98M | |||
| INVESTING CASH FLOW | -141.00M | -31.00M | 32.00M | 73.24M | -71.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 7.65M | 6.85M | 25.00M | 8.20M | 18.16M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 7.65M | 6.85M | 25.00M | 8.20M | 18.16M | |||
| Exchange Rate Effect | -110.00K | -90.00K | -20.00K | 10.00K | 10.00K | |||
| CHANGE IN CASH | 15.54M | 133.76M | 73.98M | -32.59M | -178.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 149.00M | 158.00M | 17.00M | -114.04M | -125.66M | |||
| Capital Expenditure | N/A | -520.00K | -40.00M | 0.00 | -1.12M | |||
| FREE CASH FLOW | 49.48M | 157.48M | -23.00M | -114.04M | -126.78M | |||
All data in USD